The requestor asked for information on the last five funding proposals submitted to the MRC for research involving CFS/ME patients with specified cluster of symptoms (as outlined in the request).
FOI disclosure log
This page provides access to the MRC's responses to requests made under the Freedom of Information Act and the Environmental Information Regulations. Responses to requests received from January 2017 are available here, if you would like information on previous requests please contact us (firstname.lastname@example.org). Reference numbers are assigned as requests are made and only responses are published, we do not publish the details of requests made which are subsequently withdrawn or where clarification has been sought but not received.
The requestor asked for information on finance systems used for financial management and planning, including information on costs, contracts, suppliers and support partners.
The requestor asked whether any information was collected by the MRC on the effectiveness of treatment outcomes for CFS and for information on the changes in the physical health of CFS patients, as a result of attending the CFS, clinic between 2007-2017. A number of parameters were specified.
Information on any planning work that has been carried out to understand the possible impact of Brexit on IT systems operated by or behalf of the MRC.
The requestor asked for information on ‘the changes in the physical health of CFS patients, as a result of current "treatment" practices between 2007-2017’ ‘Or in the alternative the outcome statistics known to or used by MRC’.
Information on any current or past (covering the period from Feb 2014 - Feb 2017) medical/scientific research being done by UK scientists on ayahuasca.
The requestor asked for a breakdown of MRC spend using on Government Procurement Cards from 2015 to 2017.
The requestor asked for information on “MRC plans to move forward with biomedical research into the faulty immune system of people with CFS”.
Information on alternative asset investments, including private equity, venture capital, distressed debt, mezzanine, fund of funds, infrastructure, natural resources, real estate and private debt partnerships in which MRC Pension Scheme is an investor.
Facilities management across the MRC, including head office and research units and institutes.